tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Sangamo Biosciences’ Legal Victory and Hemophilia Trial Success

Sangamo Biosciences’ Legal Victory and Hemophilia Trial Success

Confident Investing Starts Here:

Sangamo Biosciences ( (SGMO) ) has shared an announcement.

Sangamo Therapeutics faced legal challenges over a stock increase amendment, but the Delaware Court of Chancery validated the voting process, clearing uncertainties. Meanwhile, in collaboration with Pfizer, Sangamo presented promising results from the Phase 3 AFFINE trial for a gene therapy targeting hemophilia A, showing significant reductions in bleeding rates. These developments are pivotal for investors tracking Sangamo’s strategic moves and the broader gene therapy market.

See more insights into SGMO stock on TipRanks’ Stock Analysis page.

OSZAR »

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1

Latest News Feed

More Market News >

More Articles

More News >

Stock Comparison

Quantum ComputingAICryptocurrencyBitcoin StocksDividendValueBiotechOilChineseChat GPTBanksAirlineBeer & BeveragesEnergy

Investment Ideas

Analyst Top StocksSmart Score StocksStock ScreenerTop Wall Street AnalystsInsiders' Hot StocksTop Penny StocksUnusual Options ActivityTop ETFs by Upside Potential

Trending Articles:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' \\n \\n Best Online Brokers\\n \\n guide, and find the ideal broker for your trades.

Report an Issue

\",\"date\":\"2024-12-10T11:30:03.000Z\",\"description\":\"Sangamo Biosciences ( ($SGMO) ) has shared an announcement. Sangamo Therapeutics faced legal challenges over a stock increase amendment, but the Delaware Court of Chancery validated the voting process, clearing\\n\",\"image\":{\"src\":\"https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_390599908-1-750x406.jpg\",\"width\":750,\"height\":406},\"isLocked\":false,\"link\":\"/news/company-announcements/sangamo-biosciences-legal-victory-and-hemophilia-trial-success\",\"lockType\":\"GraceCount\",\"mainMarket\":\"us\",\"slug\":\"sangamo-biosciences-legal-victory-and-hemophilia-trial-success\",\"sticky\":false,\"storyHighlights\":null,\"thumbnail\":{\"src\":\"https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_390599908-1-150x150.jpg\"},\"title\":\"Sangamo Biosciences’ Legal Victory and Hemophilia Trial Success\",\"topics\":[{\"id\":0,\"type\":null,\"market\":null,\"title\":\"8K\",\"slug\":\"8k\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"8K\"},{\"id\":0,\"type\":\"stock\",\"market\":\"us\",\"title\":\"SGMO\",\"slug\":\"sgmo\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"SGMO\"},{\"id\":0,\"type\":\"stock\",\"market\":\"de\",\"title\":\"DE:GBY\",\"slug\":\"degby\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"GBY\"},{\"id\":0,\"type\":\"stock\",\"market\":\"uk\",\"title\":\"GB:0R1D\",\"slug\":\"gb0r1d\",\"sentiment\":null,\"isVisible\":true,\"displayTitle\":\"0R1D\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-CAT-LEGAL\",\"slug\":\"data-cat-legal\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-CAT-LEGAL\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-CAT-BIZOPS\",\"slug\":\"data-cat-bizops\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-CAT-BIZOPS\"},{\"id\":0,\"type\":null,\"market\":null,\"title\":\"DATA-SENTIMENT-POSITIVE\",\"slug\":\"data-sentiment-positive\",\"sentiment\":null,\"isVisible\":false,\"displayTitle\":\"DATA-SENTIMENT-POSITIVE\"}],\"words\":87,\"timeAgo\":\"6M\",\"time\":1733830203000,\"badge\":null,\"id\":1588527,\"seo\":{\"title\":\"Sangamo Biosciences’ Legal Victory and Hemophilia Trial Success\",\"description\":\"

Sangamo Biosciences ( ($SGMO) ) has shared an announcement. Sangamo Therapeutics faced legal challenges over a stock increase amendment, but the Delaware Court of C...\"},\"linkToVideo\":null,\"callToActionType\":\"design\"},\"relatedLinks\":null},\"isLoadedFromSSR\":true}}");

OSZAR »